Abacavir lamivudine zidovudine labels and packages

Revision as of 17:20, 9 January 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Abacavir lamivudine zidovudine}} {{CMG}}; {{AE}} {{SS}} ==Labels And Packages== {| |- |thumb|850px|left |- |}<ref name="dailymed.nlm.nih.gov">{...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Abacavir lamivudine zidovudine
TRIZIVIR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels And Packages

[1]

References

  1. ↑ "TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]". Retrieved 9 January 2014.

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Abacavir_lamivudine_zidovudine_labels_and_packages&oldid=930471"